AI driven expansion Cerbo recently launched AI Scribe, signaling a strategic push to embed native AI tools for independent healthcare providers. This presents a sales opportunity to offer complementary AI-enabled features, NLP-assisted documentation, and workflow automation integrations to streamline clinical notes and patient interactions.

HIPAA compliant momentum As a HIPAA-compliant EHR used by thousands of practitioners in functional and integrative medicine and direct primary care, Cerbo demonstrates strong market fit for secure, compliant practice management software. This creates opportunities to cross-sell add-ons such as secure messaging, patient portals, and lab integration solutions that align with stringent privacy requirements.

Strong partner signals Cerbo has existing connectivity with laboratories (HL7 data transmission) through DUTCHtest partnerships, indicating a readiness to expand lab and data interoperability. Sales opportunities exist to promote expanded lab integrations, test result routing, and third-party diagnostic data across broader EHR workflows.

Growth and leadership With a growth trajectory implied by a multi-million revenue range and recent leadership hire of a new CEO, there is likely openness to strategic partnerships, channel partnerships, and co-sell arrangements. This period is favorable for presenting scalable deployment models and enterprise-grade support plans.

Competitive landscape Industry chatter positioning Tabflows as a competitor suggests Cerbo operates in a competitive all-in-one EHR space. Sales outreach can emphasize Cerbo's unique functional charting, configurable patient portal, and seamless billing capabilities, while proposing differentiated value through deeper practice-specific customization and premium integrations.